東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Advances and prospects of 3-D metal-based anticancer drug candidates

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Advances and prospects of 3-D metal-based anticancer drug candidates/ by Farukh Arjmand, Sartaj Tabassum, Huzaifa Yasir Khan.
作者:	Arjmand, Farukh.
其他作者:	Tabassum, Sartaj.
出版者:	Singapore :Springer Nature Singapore : : 2024.,
面頁冊數:	xii, 284 p. :ill., digital ;24 cm.
內容註:	1. Introduction -- 2. Classification of Metal-Based Anticancer Chemotherapeutic Agents -- 3. Interaction Studies of Metal-Based Anticancer Drug Entities with Potential Therapeutic Targets -- 4. Biophysical and Spectroscopic Techniques to Validate the Interaction with Therapeutic targets -- 5. DNA Condensation Processes mediated by Metal-based Drug Entities and Morphological Studies -- 6. Molecular Docking and Computational in silico Investigations of Metal-Based Drug Agents -- 7.Biochemical Mechanistic Pathway of Cell Death Induced by Metal-Based Chemotherapeutic Agents -- 8.Combination Drug Strategies for Targeting Specific Biochemical Pathways for Superior Therapeutic Potency -- 9. Advanced Drug Delivery Strategies for Metal-Based Anticancer Drugs -- 10. Endoplasmic Reticulum(ER) Targeted Metal-Based Anticancer Chemotherapeutic Agents -- 11.Progress and Future Projections in Metal-Based Polymeric Anticancer Compounds -- 12. Conclusions.
Contained By:	Springer Nature eBook
標題:	Antineoplastic agents. -
電子資源:	https://doi.org/10.1007/978-981-97-0146-9
ISBN:	9789819701469

Advances and prospects of 3-D metal-based anticancer drug candidates
Arjmand, Farukh.

Advances and prospects of 3-D metal-based anticancer drug candidates[electronic resource] /by Farukh Arjmand, Sartaj Tabassum, Huzaifa Yasir Khan. - Singapore :Springer Nature Singapore :2024. - xii, 284 p. :ill., digital ;24 cm.

1. Introduction -- 2. Classification of Metal-Based Anticancer Chemotherapeutic Agents -- 3. Interaction Studies of Metal-Based Anticancer Drug Entities with Potential Therapeutic Targets -- 4. Biophysical and Spectroscopic Techniques to Validate the Interaction with Therapeutic targets -- 5. DNA Condensation Processes mediated by Metal-based Drug Entities and Morphological Studies -- 6. Molecular Docking and Computational in silico Investigations of Metal-Based Drug Agents -- 7.Biochemical Mechanistic Pathway of Cell Death Induced by Metal-Based Chemotherapeutic Agents -- 8.Combination Drug Strategies for Targeting Specific Biochemical Pathways for Superior Therapeutic Potency -- 9. Advanced Drug Delivery Strategies for Metal-Based Anticancer Drugs -- 10. Endoplasmic Reticulum(ER) Targeted Metal-Based Anticancer Chemotherapeutic Agents -- 11.Progress and Future Projections in Metal-Based Polymeric Anticancer Compounds -- 12. Conclusions.

This book reviews the potential of metallodrugs against different cancer. It summarizes the classification of metal-based anti-cancer drugs, their plausible biochemical and mechanistic pathways, combining drug strategies for hitting multiple therapeutic targets at the intracellular level, and advanced drug delivery strategies. The book covers the metallodrugs for the efficacious treatment of diverse cancerous strains and recent advances in drug delivery strategies that are used for developing these metal-based therapeutics as potent anticancer agents in vitro and in vivo. The book also covers different biophysical and analytical techniques for studying metal-ligand and metal-macromolecular interactions. The book further presents the recent examples of metallomics studies on the different types of cell death induced by metal-based anticancer drugs, especially on the three major forms of programmed cell death (PCD) in mammalian cells: apoptosis, autophagy, and regulated necrosis, also called necroptosis. Lastly, the book explores the modulation of reactive oxygen species (ROS) by metallodrugs.

ISBN: 9789819701469

Standard No.: 10.1007/978-981-97-0146-9doiSubjects--Topical Terms:

795427
Antineoplastic agents.

LC Class. No.: RS431.A64

Dewey Class. No.: 615.798

Advances and prospects of 3-D metal-based anticancer drug candidates
LDR:03096nmm a22003255a 4500 001 2369541
003 DE-He213
005 20240503103332.0
006 m d
007 cr nn 008maaau
008 241127s2024 si s 0 eng d
020 $a 9789819701469 $q (electronic bk.)
020 $a 9789819701452 $q (paper)
024 7 $a 10.1007/978-981-97-0146-9 $2 doi
035 $a 978-981-97-0146-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RS431.A64
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 615.798 $2 23
090 $a RS431.A64 $b A719 2024
100 1 $a Arjmand, Farukh. $3 3714274
245 1 0 $a Advances and prospects of 3-D metal-based anticancer drug candidates $h [electronic resource] / $c by Farukh Arjmand, Sartaj Tabassum, Huzaifa Yasir Khan.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xii, 284 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Introduction -- 2. Classification of Metal-Based Anticancer Chemotherapeutic Agents -- 3. Interaction Studies of Metal-Based Anticancer Drug Entities with Potential Therapeutic Targets -- 4. Biophysical and Spectroscopic Techniques to Validate the Interaction with Therapeutic targets -- 5. DNA Condensation Processes mediated by Metal-based Drug Entities and Morphological Studies -- 6. Molecular Docking and Computational in silico Investigations of Metal-Based Drug Agents -- 7.Biochemical Mechanistic Pathway of Cell Death Induced by Metal-Based Chemotherapeutic Agents -- 8.Combination Drug Strategies for Targeting Specific Biochemical Pathways for Superior Therapeutic Potency -- 9. Advanced Drug Delivery Strategies for Metal-Based Anticancer Drugs -- 10. Endoplasmic Reticulum(ER) Targeted Metal-Based Anticancer Chemotherapeutic Agents -- 11.Progress and Future Projections in Metal-Based Polymeric Anticancer Compounds -- 12. Conclusions.
520 $a This book reviews the potential of metallodrugs against different cancer. It summarizes the classification of metal-based anti-cancer drugs, their plausible biochemical and mechanistic pathways, combining drug strategies for hitting multiple therapeutic targets at the intracellular level, and advanced drug delivery strategies. The book covers the metallodrugs for the efficacious treatment of diverse cancerous strains and recent advances in drug delivery strategies that are used for developing these metal-based therapeutics as potent anticancer agents in vitro and in vivo. The book also covers different biophysical and analytical techniques for studying metal-ligand and metal-macromolecular interactions. The book further presents the recent examples of metallomics studies on the different types of cell death induced by metal-based anticancer drugs, especially on the three major forms of programmed cell death (PCD) in mammalian cells: apoptosis, autophagy, and regulated necrosis, also called necroptosis. Lastly, the book explores the modulation of reactive oxygen species (ROS) by metallodrugs.
650 0 $a Antineoplastic agents. $3 795427
650 0 $a Cancer $x Chemotherapy. $3 753516
650 0 $a Metals in medicine. $3 1534645
650 1 4 $a Cancer Therapy. $3 3594090
650 2 4 $a Cancer Metabolism. $3 3607000
650 2 4 $a Biochemistry. $3 518028
700 1 $a Tabassum, Sartaj. $3 3714275
700 1 $a Khan, Huzaifa Yasir. $3 3714276
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-97-0146-9
950 $a Biomedical and Life Sciences (SpringerNature-11642)